Camber Pharmaceuticals Launches Generic Ranexa®

Piscataway, NJ, March 3, 2023–Camber Pharmaceuticals is pleased to announce the addition of Ranolazine ER Tablets to its current portfolio.
Ranolazine ER Tablets is a prescription medicine used to treat angina that keeps coming back (chronic angina).
Ranolazine ER Tablets may be used with other medicines that are used for heart problems and blood pressure control.
Ranolazine ER Tablets are available in 500 and 1000 mg strengths and supplied in 60 count bottles.
To find out more about Ranolazine ER Tablets please visit www.camberpharma.com
Camber Pharmaceuticals is a fully integrated pharmaceutical company. Its parent company, Hetero, of Hyderabad, India, is one of the world’s leading API and finished dosage manufacturers. Camber is committed to bringing the highest quality generic pharmaceuticals to consumers, improving quality of life through cost-effective medications.
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection